CONMED Corp Files 8-K for Shareholder Votes & Other Events

TL;DR

CONMED filed an 8-K for shareholder votes and other events. Nothing specific yet.

AI Summary

CONMED Corporation filed an 8-K on May 22, 2024, to report on matters submitted to a vote of security holders and other events. The filing does not contain specific details on the votes or events, but it serves as an official notification to the SEC.

Why It Matters

This filing indicates that CONMED Corporation has held or is holding votes for its security holders and has other corporate events to report, which are important for transparency and investor awareness.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of corporate events and shareholder votes, not indicating any immediate financial distress or significant operational change.

Key Numbers

• 001-39218 — Commission File Number (Identifies CONMED Corporation's SEC filings)
• 16-0977505 — I.R.S. Employer Identification No. (Tax identification for CONMED Corporation)

Key Players & Entities

• CONMED Corporation (company) — Registrant
• Delaware (jurisdiction) — State of incorporation
• May 22, 2024 (date) — Date of earliest event reported

FAQ

Key Financial Figures

• $0.01 — nge on which registered Common Stock, $0.01 par value CNMD NYSE Indicate by che
• $0.20 — s declared a quarterly cash dividend of $0.20 per share on May 22, 2024, payable on J

Filing Documents

• tm2415336d1_8k.htm (8-K) — 36KB
• 0001104659-24-064334.txt ( ) — 204KB
• cnmd-20240522.xsd (EX-101.SCH) — 3KB
• cnmd-20240522_lab.xml (EX-101.LAB) — 33KB
• cnmd-20240522_pre.xml (EX-101.PRE) — 22KB
• tm2415336d1_8k_htm.xml (XML) — 3KB

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. At the Company's Annual Meeting of Stockholders held on May 22, 2024, stockholders voted on three proposals and cast their votes as follows: 1. The following table sets forth the names of the eight persons elected at the Annual Meeting to serve as directors until the first annual meeting of stockholders following the end of the Company's fiscal year ending December 31, 2024, and the number of votes cast for, against or withheld with respect to each person. Shares Name For Withhold Broker Non-Votes David Bronson 26,957,962 1,243,603 1,191,876 Brian Concannon 26,993,282 1,208,283 1,191,876 LaVerne Council 27,159,969 1,041,596 1,191,876 Charles Farkas 27,218,074 983,491 1,191,876 Martha Goldberg Aronson 27,365,061 836,504 1,191,876 Curt. R. Hartman 26,177,581 2,019,802 1,196,058 Barbara Schwarzentraub 27,327,255 874,310 1,191,876 John L. Workman 27,287,635 913,930 1,191,876 2. The advisory vote on the resolution relating to compensation of our named executive officers passed based upon the following votes: Shares For Against Abstain Broker Non-Votes 27,090,070 1,069,964 41,569 1,191,838 3. The appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal 2024 was ratified based on the following votes: Shares For Against Abstain Broker Non-Votes 27,290,715 2,097,183 5,543 0

01 Other Events

Item 8.01 Other Events CONMED Corporation announced its Board of Directors declared a quarterly cash dividend of $0.20 per share on May 22, 2024, payable on July 5, 2024, to all shareholders of record as of June 14, 2024. Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: May 22, 2024 CONMED CORPORATION (Registrant) By: /s/ Todd W. Garner Name: Todd W. Garner Title: Executive Vice President, Finance and Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR